Female Slings for Stress Urinary Incontinence (SUI)

Effective surgical options for managing stress urinary incontinence

Stress urinary incontinence (SUI) is urine leakage caused by physical activity, coughing, laughing, or sneezing. Female slings are a surgical option designed to support the urethra and prevent leakage when conservative treatments fail. Midurethral slings using synthetic mesh are well-studied, safe, and effective, with long-term data supporting their use; autologous fascial slings offer a non-mesh alternative for certain patients, particularly those with severe SUI or prior unsuccessful surgery.

Stress urinary incontinence (SUI) occurs when the urethra sags out of place or when the sphincter controlling urine flow is weak. Slings act like a hammock under the urethra, providing support and pressure to keep it closed, and are recommended for women whose SUI does not improve with non-surgical approaches. Midurethral slings are distinguished from transvaginal mesh for pelvic organ prolapse (POP), which has higher complication rates and has been restricted by the FDA.

What is a Female Sling?

The surgical procedure to place a supportive sling under the urethra prevents urine leakage and stabilizes the bladder neck. There are several types of slings:

  • Retropubic sling – Goes up behind the pubic bone toward the lower abdomen, which may be slightly more effective for severe leakage but carries a higher risk of bladder injury or voiding difficulty.
  • Transobturator sling (TOT) – Goes through the groin on each side, avoiding the space behind the pubic bone, which lowers the risk of bladder injury but can cause more inner thigh discomfort.
  • Single-incision sling – Uses a much shorter piece of mesh placed through a small vaginal incision with no exit points, making it less invasive but sometimes a bit less durable for more severe leakage.
  • Autologous fascial sling – This procedure uses the patient’s own tissue (from the lower abdomen or thigh) to support the urethra at the bladder neck, and is usually reserved for:
    • Severe SUI
    • Intrinsic sphincter deficiency
    • Non-mobile urethra
    • Concurrent urethral reconstruction

The surgical materials used include synthetic mesh or autologous tissue (the patient’s own). Sling placement tends to be minimally invasive for mesh slings and more invasive for autologous slings.

What is the Difference Between Mesh and Autologous Surgical  Material?

Mesh, or synthetic, slings are typically used in tension-free slings and rely on the body forming scar tissue to hold them in place. They are typically less invasive and use smaller incisions. This type of mesh is supported by the FDA and follow-up data¹, and the American Urological Association (AUA) guideline on SUI cites midurethral slings as a viable option with few exceptions.²

As with any surgery that incorporates synthetic materials, there are risks. Using synthetic mesh slings can lead to erosion, pain, and infection, and while rare, serious complications may require additional surgery for mesh removal. However, they remain the gold standard for this type of procedure, with the AUA endorsing advantages such as shorter operating time, less pain from the surgery itself, shorter hospital stay, and a lower risk of voiding dysfunction.³

Autologous, or fascial, slings use the patient’s own tissue from the abdomen or thigh, and are placed at the bladder neck, rather than mid-urethra. This version tends to involve a more invasive, longer procedure and hospital stay. Studies show comparable efficacy to synthetic slings, but autologous procedures may carry slightly higher adverse effects due to tissue harvesting, longer operative time, and potential for wound complications.⁴

The advantages of autologous slings are that they avoid synthetic material-related risks and are suitable when mesh is contraindicated, or prior mesh procedures failed.⁵ It may also be indicated when multiple surgeries are involved.

What to Expect Before, During, and After the Procedure

When surgical options are approached for the treatment of SUI, your physician will begin with an evaluation of urinary symptoms, prior treatments, and medical history. Conservative treatments like pelvic floor exercises, urethral bulking, or bladder training are usually attempted first. When these methods fail, patients are counseled on advanced options as well as material options for surgical repair (mesh vs. autologous tissue). Preoperative analysis might include urodynamics, urine tests to rule out UTI, lab work, and other surgical clearance testing.

A procedure utilizing synthetic mesh is minimally invasive via a vaginal incision, and an intraoperative cystoscopy is often performed. This is a safe, highly effective endoscopic procedure used during pelvic surgery, including hysterectomies and prolapse repairs, to immediately detect, prevent, and manage lower urinary tract injuries. Using a camera, surgeons can verify bladder integrity, healthy ureteral openings, and urine flow, preventing serious, delayed postoperative complications.

In an autologous procedure, fascia is harvested from the lower abdomen or thigh, and the native tissue sling is tunneled under the bladder neck and secured with sutures. Cystoscopy is also used to confirm bladder and associated structure integrity.

In both procedures, a catheter is used to temporarily drain the bladder while swelling around the urethra subsides, allowing the patient to empty their bladder properly as the sling settles.

Both procedures also require activity restrictions in which heavy lifting and sexual intercourse must be avoided. Straining during bowel movements is also avoided by using stool softeners. Proper hydration and adequate fiber intake will also alleviate bowel movement issues.

Total recovery for a mesh procedure can take up to 4 weeks, while recovery from an autologous procedure can take up to 6 weeks. Patients are advised to monitor for unusual or severe pain, urinary retention, and infection. Staying mobile during recovery, such as gentle walking, is recommended to avoid clotting events, which are a risk after any surgery.

Follow-up appointments are to the patient’s benefit so that urinary function and healing can be assessed, and complications avoided. Adverse events can occur with either surgery, even after healing, so prolonged follow-ups are recommended to detect and manage this early.

If stress urinary incontinence is affecting your quality of life, a consultation with a women’s health specialist at Georgia Urology can help determine the best treatment path. Options range from conservative measures (pelvic floor physical therapy, bladder training, or pessaries) to surgical interventions. Early evaluation will give you the best chance for safe, effective relief.

Don’t let incontinence rule your life. Contact our team at GU and take the first step toward regaining control and confidence.

FAQs

When are slings recommended for stress urinary incontinence (SUI)?

Slings are considered when conservative treatments, such as pelvic floor exercises, bladder training, or pessaries, fail to adequately control SUI.

How is the type of sling chosen?

Sling selection depends on patient anatomy, severity of SUI, history of prior surgeries, and patient preference.

Do FDA and AUA restrictions on transvaginal mesh for pelvic organ prolapse (POP) apply to SUI midurethral slings?

No. Restrictions for transvaginal POP mesh do not apply to midurethral slings for SUI, which remain supported by both the FDA and American Urological Association (AUA) guidance.

How does surgeon experience affect outcomes?

Surgeon training and case volume impact complication rates. Well-versed and experienced surgeons typically achieve lower rates of adverse events.

What are mini-slings and how reliable are they?

Mini-slings are shorter, less invasive midurethral slings. Long-term data are still limited, so their use is more selective.

What are first-line treatments for SUI?

Pelvic floor muscle training (PFMT) supervised by a trained physiotherapist is the most common first-line approach. Bulkamid is also a less invasive first-line treatment that adds “bulk” to the urethra with a water-based gel. It restores the urethra’s natural closing mechanism to stop involuntary urine leaks.

Can lifestyle changes help with SUI?

It’s possible. Healthy weight loss and diet modifications can reduce symptoms, and some vaginal devices can help manage leakage during physical activity.

Are medications an option for SUI?

No, SUI is an anatomic problem that needs to be addressed with an anatomic repair.

Resources:

  1. U.S. Food and Drug Administration. (2024). Stress Urinary Incontinence: Surgical Mesh Considerations and Recommendations. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/urogynecologic-surgical-mesh-implants/stress-urinary-incontinence-surgical-mesh-considerations-and-recommendations.
  2. American Urological Association. (2023). Surgical Treatment of Female Stress Urinary Incontinence (SUI): AUA/SUFU Guideline. Www.auanet.org. https://www.auanet.org/guidelines-and-quality/guidelines/stress-urinary-incontinence-(sui)-guideline.
  3. American Urological Association. (2019, May). AUA Position Statement on the Use of Vaginal Mesh for the Surgical Treatment of Stress Urinary Incontinence (SUI). Auanet.org. https://www.auanet.org/about-us/aua-statements/use-of-vaginal-mesh-for-the-surgical-treatment-of-stress-urinary-incontinence.
  4. Dogan S. (2022). Comparison of Autologous Rectus Fascia and Synthetic Sling Methods of Transobturator Mid-Urethral Sling in Urinary Stress Incontinence. Cureus, 14(3), e23278. https://doi.org/10.7759/cureus.23278.
  5. Kluivers, K. B., Kamping, M., Milani, A. L., IntHout, J., & Withagen, M. I. (2023). Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial. International urogynecology journal, 34(7), 1645–1651. https://doi.org/10.1007/s00192-022-05442-9.
Shaya Taghechian, MD

This page was reviewed by Shaya Taghechian, MD

A native of Atlanta, Dr. Taghechian received her bachelor’s degree in biology and chemistry from Emory University. She continued at Emory University, in the School of Medicine, where she completed her medical degree. Following that, she completed a residency in surgery and urology at the University of Texas in Houston. She joined Georgia Urology in 2011.

Schedule an Appointment